Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3510LO1W
Performance in the last:
Follow this Portfolio
1D 0.2 %
1W 1.1 %
2W 1.1 %
1M -1.4 %
3M 0.8 %
6M 2.7 %
9M -2.4 %
1Y 32.7 %
Alpha
18.3%
Beta
0.45
sharpe-R
1.24
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.64
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-12-03 08:16:55
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -9.45%
Max. DrawDown Benchmark -8.41%

This Long Only strategy aims to find promising assets to invest in for a maximum holding period of 1 Week in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 10.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
2

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.52% 8.55%
MGNX MacroGenics, Inc. Buy 10.52% 8.53%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.76% 0.73%
ESPR Esperion Therapeutics, Inc. Buy 9.6% 0%
The percentage of cash held in the portfolio is: 59.6%
** The description of each asset is available Here

The latest 5 Compositions change

2024-12-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.52% 8.55%
MGNX MacroGenics, Inc. Buy 10.52% 8.53%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.76% 0.73%
ESPR Esperion Therapeutics, Inc. Buy 9.6% 0%
The percentage of cash held in the portfolio is: 59.6%
New Assets Added
  • ESPR
Assets Removed
Asset Action Perf %
FATE Sell All -6.62%
Assets Rebalanced
None
2024-11-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.14% 4.63%
MGNX MacroGenics, Inc. Buy 10.37% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.69% 0%
FATE Fate Therapeutics, Inc. Buy 9.69% 0%
The percentage of cash held in the portfolio is: 60.12%
New Assets Added
  • ARWR
  • FATE
Assets Removed
None
Assets Rebalanced
None
2024-11-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 9.8% 0%
MGNX MacroGenics, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • APLS
  • MGNX
Assets Removed
None
Assets Rebalanced
None
2024-11-19 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
MDRX Sell All -4.98%
Assets Rebalanced
None
2024-11-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.39% -5.24%
The percentage of cash held in the portfolio is: 89.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
RGEN Sell All -17.11%
TGTX Sell All -3.9%
ITGR Sell All -2.62%
FGEN Sell All 3.72%
Assets Rebalanced
None
2024-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
ITGR Integer Holdings Corporation Buy 9.46% -1.41%
FGEN FibroGen, Inc. Buy 10.99% 14.55%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.23% -3.91%
TGTX TG Therapeutics, Inc. Buy 10.69% 0.34%
RGEN Repligen Corporation Buy 9.17% -5.34%
The percentage of cash held in the portfolio is: 49.46%
New Assets Added
None
Assets Removed
Asset Action Perf %
SAGE Sell All -15.03%
CHRS Sell All -5.73%
Assets Rebalanced
None
2024-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
SAGE Sage Therapeutics, Inc. Buy 9.1% -9.34%
CHRS Coherus BioSciences, Inc. Buy 9.54% -5%
ITGR Integer Holdings Corporation Buy 9.46% 0.58%
FGEN FibroGen, Inc. Buy 9.67% 2.79%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.35% -0.89%
TGTX TG Therapeutics, Inc. Buy 11.86% 13.53%
RGEN Repligen Corporation Buy 9.5% 0%
The percentage of cash held in the portfolio is: 30.51%
New Assets Added
  • RGEN
Assets Removed
Asset Action Perf %
ARCT Sell All -2.29%
CARA Sell All -6.09%
HUM Sell All 0.32%
ESPR Sell All -11.51%
Assets Rebalanced
None
2024-11-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
HUM Humana Inc. Buy 9.68% -2.1%
CARA Cara Therapeutics, Inc. Buy 9.74% -1.16%
SAGE Sage Therapeutics, Inc. Buy 9.82% -0.32%
CHRS Coherus BioSciences, Inc. Buy 9.36% -5%
ITGR Integer Holdings Corporation Buy 9.41% 2%
ARCT Arcturus Therapeutics Holdings Inc. Buy 9.57% 3.77%
FGEN FibroGen, Inc. Buy 9.68% 4.95%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.25% 0%
ESPR Esperion Therapeutics, Inc. Buy 10.25% 0%
TGTX TG Therapeutics, Inc. Buy 10.25% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
  • ESPR
  • TGTX
Assets Removed
Asset Action Perf %
IRTC Sell All 9.2%
CORT Sell All 17.98%
Assets Rebalanced
None
2024-11-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRTC iRhythm Technologies, Inc. Buy 10.12% 6.19%
CORT Corcept Therapeutics Incorporated Buy 11.34% 19.06%
HUM Humana Inc. Buy 9.93% -0.14%
CARA Cara Therapeutics, Inc. Buy 9.76% -1.45%
SAGE Sage Therapeutics, Inc. Buy 9.89% -0.16%
CHRS Coherus BioSciences, Inc. Buy 9.84% -0.61%
ITGR Integer Holdings Corporation Buy 9.28% 0%
ARCT Arcturus Therapeutics Holdings Inc. Buy 9.28% 0%
FGEN FibroGen, Inc. Buy 9.28% 0%
The percentage of cash held in the portfolio is: 11.28%
New Assets Added
  • ITGR
  • ARCT
  • FGEN
Assets Removed
Asset Action Perf %
AMN Sell All -29.49%
IART Sell All -0.52%
MGNX Sell All 12.4%
Assets Rebalanced
None
2024-11-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
MGNX MacroGenics, Inc. Buy 10.47% 15.25%
IRTC iRhythm Technologies, Inc. Buy 10.09% 8.99%
CORT Corcept Therapeutics Incorporated Buy 10.04% 8.47%
IART Integra LifeSciences Holdings Corporation Buy 9.63% 2.41%
HUM Humana Inc. Buy 9.64% -0.26%
AMN AMN Healthcare Services, Inc. Buy 9.6% -0.68%
CARA Cara Therapeutics, Inc. Buy 9.63% 0%
SAGE Sage Therapeutics, Inc. Buy 9.63% 0%
CHRS Coherus BioSciences, Inc. Buy 9.63% 0%
The percentage of cash held in the portfolio is: 11.63%
New Assets Added
  • CARA
  • SAGE
  • CHRS
Assets Removed
Asset Action Perf %
ATEC Sell All 19.87%
AVXL Sell All 15.33%
MCRB Sell All -12.8%
ORMP Sell All 0%
Assets Rebalanced
None
2024-11-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATEC Alphatec Holdings, Inc. Buy 10.32% 12.99%
AVXL Anavex Life Sciences Corp. Buy 10.74% 17.67%
MCRB Seres Therapeutics, Inc. Buy 8.41% -7.93%
ORMP Oramed Pharmaceuticals Inc. Buy 8.98% -1.68%
MGNX MacroGenics, Inc. Buy 9.85% 8.27%
IRTC iRhythm Technologies, Inc. Buy 10.19% 9.9%
CORT Corcept Therapeutics Incorporated Buy 10.05% 8.33%
IART Integra LifeSciences Holdings Corporation Buy 10.1% 7.19%
HUM Humana Inc. Buy 9.68% 0%
AMN AMN Healthcare Services, Inc. Buy 9.68% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HUM
  • AMN
Assets Removed
Asset Action Perf %
NVRO Sell All 7.04%
INCY Sell All 9.5%
Assets Rebalanced
None
2024-11-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVRO Nevro Corp. Buy 9.52% 2.96%
INCY Incyte Corporation Buy 9.67% 4.53%
ATEC Alphatec Holdings, Inc. Buy 10.29% 9.3%
AVXL Anavex Life Sciences Corp. Buy 10.95% 16.31%
MCRB Seres Therapeutics, Inc. Buy 9.32% -0.98%
ORMP Oramed Pharmaceuticals Inc. Buy 9.29% -1.26%
MGNX MacroGenics, Inc. Buy 9.14% -2.58%
IRTC iRhythm Technologies, Inc. Buy 10.17% 6.43%
CORT Corcept Therapeutics Incorporated Buy 9.95% 4.16%
IART Integra LifeSciences Holdings Corporation Buy 9.71% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • IART
Assets Removed
Asset Action Perf %
NEOG Sell All 4.74%
Assets Rebalanced
None
2024-11-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
NEOG Neogen Corporation Buy 9.66% 0.63%
NVRO Nevro Corp. Buy 9.43% -0.93%
INCY Incyte Corporation Buy 9.75% 2.46%
ATEC Alphatec Holdings, Inc. Buy 10.32% 6.5%
AVXL Anavex Life Sciences Corp. Buy 10.68% 10.27%
MCRB Seres Therapeutics, Inc. Buy 9.53% -1.59%
ORMP Oramed Pharmaceuticals Inc. Buy 9.73% 0.42%
MGNX MacroGenics, Inc. Buy 9.23% -4.39%
IRTC iRhythm Technologies, Inc. Buy 9.84% 0%
CORT Corcept Therapeutics Incorporated Buy 9.84% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • IRTC
  • CORT
Assets Removed
Asset Action Perf %
HCSG Sell All 2.01%
IOVA Sell All 3.72%
Assets Rebalanced
None
2024-11-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 9.8% 1.83%
IOVA Iovance Biotherapeutics, Inc. Buy 9.76% 1.45%
NEOG Neogen Corporation Buy 9.72% 0.7%
NVRO Nevro Corp. Buy 9.8% 2.41%
INCY Incyte Corporation Buy 9.85% 2.98%
ATEC Alphatec Holdings, Inc. Buy 10.06% 3.31%
AVXL Anavex Life Sciences Corp. Buy 10.05% 3.25%
MCRB Seres Therapeutics, Inc. Buy 9.76% 0.24%
ORMP Oramed Pharmaceuticals Inc. Buy 9.49% -2.52%
MGNX MacroGenics, Inc. Buy 9.71% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MGNX
Assets Removed
None
Assets Rebalanced
None
2024-11-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 9.8% 0.18%
IOVA Iovance Biotherapeutics, Inc. Buy 9.26% -5.35%
NEOG Neogen Corporation Buy 9.77% -0.42%
NVRO Nevro Corp. Buy 9.93% 2.04%
INCY Incyte Corporation Buy 9.75% 0.26%
ATEC Alphatec Holdings, Inc. Buy 9.9% 0%
AVXL Anavex Life Sciences Corp. Buy 9.9% 0%
MCRB Seres Therapeutics, Inc. Buy 9.9% 0%
ORMP Oramed Pharmaceuticals Inc. Buy 9.9% 0%
The percentage of cash held in the portfolio is: 11.9%
New Assets Added
  • ATEC
  • AVXL
  • MCRB
  • ORMP
Assets Removed
Asset Action Perf %
VKTX Sell All -0.93%
IBRX Sell All 23.75%
SGMO Sell All -16.67%
Assets Rebalanced
None
2024-10-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
VKTX Viking Therapeutics, Inc. Buy 9.34% -2.01%
IBRX ImmunityBio, Inc. Buy 12.76% 33.97%
HCSG Healthcare Services Group, Inc. Buy 9.59% 0.91%
SGMO Sangamo Therapeutics, Inc. Buy 9.27% -2.45%
IOVA Iovance Biotherapeutics, Inc. Buy 9.52% 0.09%
NEOG Neogen Corporation Buy 9.69% 1.6%
NVRO Nevro Corp. Buy 9.46% 0%
INCY Incyte Corporation Buy 9.46% 0%
The percentage of cash held in the portfolio is: 20.91%
New Assets Added
  • NVRO
  • INCY
Assets Removed
Asset Action Perf %
ALGN Sell All -2.57%
CDMO Sell All -2.03%
Assets Rebalanced
None
2024-10-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 9.51% -1.74%
ALGN Align Technology, Inc. Buy 9.37% -1.68%
VKTX Viking Therapeutics, Inc. Buy 9.55% 0.18%
IBRX ImmunityBio, Inc. Buy 12.71% 33.25%
HCSG Healthcare Services Group, Inc. Buy 9.58% 0.64%
SGMO Sangamo Therapeutics, Inc. Buy 9.33% -1.96%
IOVA Iovance Biotherapeutics, Inc. Buy 9.33% -1.99%
NEOG Neogen Corporation Buy 9.54% 0%
The percentage of cash held in the portfolio is: 21.09%
New Assets Added
  • NEOG
Assets Removed
Asset Action Perf %
NUTX Sell All -10.96%
PTCT Sell All 8.09%
Assets Rebalanced
None
2024-10-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 9.17% -3.3%
PTCT PTC Therapeutics, Inc. Buy 9.76% 2.95%
CDMO Avid Bioservices, Inc. Buy 9.24% -2.51%
ALGN Align Technology, Inc. Buy 9.32% -0.29%
VKTX Viking Therapeutics, Inc. Buy 9.51% 1.78%
IBRX ImmunityBio, Inc. Buy 13.7% 46.56%
HCSG Healthcare Services Group, Inc. Buy 9.32% 0%
SGMO Sangamo Therapeutics, Inc. Buy 9.32% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 9.32% 0%
The percentage of cash held in the portfolio is: 11.32%
New Assets Added
  • HCSG
  • SGMO
  • IOVA
Assets Removed
None
Assets Rebalanced
None
2024-10-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 9.78% -0.97%
PTCT PTC Therapeutics, Inc. Buy 10.4% 5.29%
CDMO Avid Bioservices, Inc. Buy 9.73% -1.45%
ALGN Align Technology, Inc. Buy 9.73% 0%
VKTX Viking Therapeutics, Inc. Buy 9.73% 0%
IBRX ImmunityBio, Inc. Buy 9.73% 0%
The percentage of cash held in the portfolio is: 40.91%
New Assets Added
  • ALGN
  • VKTX
  • IBRX
Assets Removed
Asset Action Perf %
VREX Sell All 5.95%
NKTR Sell All -6.9%
Assets Rebalanced
None
2024-10-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 9.88% 5.37%
NKTR Nektar Therapeutics Buy 9.12% -2.76%
NUTX Nutex Health Inc. Buy 9.36% -4.88%
PTCT PTC Therapeutics, Inc. Buy 10.63% 8.04%
CDMO Avid Bioservices, Inc. Buy 9.84% 0%
The percentage of cash held in the portfolio is: 51.18%
New Assets Added
  • CDMO
Assets Removed
None
Assets Rebalanced
None
2024-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 9.74% 3.64%
NKTR Nektar Therapeutics Buy 9.34% -0.69%
NUTX Nutex Health Inc. Buy 9.86% 0%
PTCT PTC Therapeutics, Inc. Buy 9.86% 0%
The percentage of cash held in the portfolio is: 61.19%
New Assets Added
  • NUTX
  • PTCT
Assets Removed
Asset Action Perf %
CDXS Sell All -2.65%
SGMO Sell All 24.74%
ORGO Sell All -3.13%
Assets Rebalanced
None
2024-10-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDXS Codexis, Inc. Buy 9.58% -2.95%
SGMO Sangamo Therapeutics, Inc. Buy 9.26% -6.19%
ORGO Organogenesis Holdings Inc. Buy 9.59% -2.81%
VREX Varex Imaging Corporation Buy 10.12% 4.13%
NKTR Nektar Therapeutics Buy 9.31% -4.14%
The percentage of cash held in the portfolio is: 52.13%
New Assets Added
None
Assets Removed
Asset Action Perf %
BKD Sell All 3.8%
ARWR Sell All 5.84%
VCEL Sell All -2.16%
Assets Rebalanced
None
2024-10-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
BKD Brookdale Senior Living Inc. Buy 10.58% 8.76%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.64% 9.4%
VCEL Vericel Corporation Buy 9.63% -1.02%
CDXS Codexis, Inc. Buy 9.78% 0.59%
SGMO Sangamo Therapeutics, Inc. Buy 9.23% -5.08%
ORGO Organogenesis Holdings Inc. Buy 9.6% -1.25%
VREX Varex Imaging Corporation Buy 9.77% 2.07%
NKTR Nektar Therapeutics Buy 9.31% -2.76%
The percentage of cash held in the portfolio is: 21.45%
New Assets Added
None
Assets Removed
Asset Action Perf %
ARDX Sell All -3.31%
IRWD Sell All 3.29%
Assets Rebalanced
None
2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.43% -3.48%
IRWD Ironwood Pharmaceuticals, Inc. Buy 10.18% 4.23%
BKD Brookdale Senior Living Inc. Buy 10.67% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.51% 7.64%
VCEL Vericel Corporation Buy 9.44% -3.37%
CDXS Codexis, Inc. Buy 9.71% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 9.46% -3.09%
ORGO Organogenesis Holdings Inc. Buy 9.37% -4.06%
VREX Varex Imaging Corporation Buy 9.61% 0%
NKTR Nektar Therapeutics Buy 9.61% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • VREX
  • NKTR
Assets Removed
Asset Action Perf %
RDNT Sell All -3.2%
Assets Rebalanced
None
2024-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.64% -1.16%
IRWD Ironwood Pharmaceuticals, Inc. Buy 10.05% 3.05%
BKD Brookdale Senior Living Inc. Buy 9.79% 0.33%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.02% 2.69%
VCEL Vericel Corporation Buy 9.72% -0.33%
RDNT RadNet, Inc. Buy 9.77% 0.2%
CDXS Codexis, Inc. Buy 9.75% 0%
SGMO Sangamo Therapeutics, Inc. Buy 9.75% 0%
ORGO Organogenesis Holdings Inc. Buy 9.75% 0%
The percentage of cash held in the portfolio is: 11.75%
New Assets Added
  • CDXS
  • SGMO
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.72% -0.83%
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.87% 0.7%
BKD Brookdale Senior Living Inc. Buy 9.8% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 9.8% 0%
VCEL Vericel Corporation Buy 9.8% 0%
RDNT RadNet, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 41.2%
New Assets Added
  • BKD
  • ARWR
  • VCEL
  • RDNT
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.8% 0%
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • ARDX
  • IRWD
Assets Removed
Asset Action Perf %
ORGO Sell All -0.32%
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 9.7% -1.95%
The percentage of cash held in the portfolio is: 90.3%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -6.07%
Assets Rebalanced
None
2024-10-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
BCRX BioCryst Pharmaceuticals, Inc. Buy 9.44% -4.35%
ORGO Organogenesis Holdings Inc. Buy 9.68% -1.95%
The percentage of cash held in the portfolio is: 80.88%
New Assets Added
None
Assets Removed
Asset Action Perf %
IRWD Sell All -1.17%
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.88% 0.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 9.79% 0%
ORGO Organogenesis Holdings Inc. Buy 9.79% 0%
The percentage of cash held in the portfolio is: 70.54%
New Assets Added
  • BCRX
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 90.2%
New Assets Added
  • IRWD
Assets Removed
None
Assets Rebalanced
None
2024-09-16 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
MYGN Sell All 2.3%
Assets Rebalanced
None
2024-09-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
MYGN Myriad Genetics, Inc. Buy 9.32% -2.15%
The percentage of cash held in the portfolio is: 90.68%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVCR Sell All -3.99%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 9.12% -6.37%
MYGN Myriad Genetics, Inc. Buy 9.55% 0.26%
The percentage of cash held in the portfolio is: 81.33%
New Assets Added
None
Assets Removed
Asset Action Perf %
TVTX Sell All 33.75%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
TVTX Travere Therapeutics, Inc. Buy 13.14% 33.96%
NVCR NovoCure Limited Buy 8.97% -7.98%
MYGN Myriad Genetics, Inc. Buy 9.6% 0.63%
The percentage of cash held in the portfolio is: 68.29%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
TVTX Travere Therapeutics, Inc. Buy 11.39% 14.37%
ALDX Aldeyra Therapeutics, Inc. Buy 9.59% -3.01%
NVCR NovoCure Limited Buy 9.25% -6.48%
MYGN Myriad Genetics, Inc. Buy 9.68% 0%
The percentage of cash held in the portfolio is: 60.08%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
MGNX Sell All -7.41%
ESPR Sell All -9.84%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
MGNX MacroGenics, Inc. Buy 9.58% -3.7%
ESPR Esperion Therapeutics, Inc. Buy 9.35% -6.01%
TVTX Travere Therapeutics, Inc. Buy 10.24% 3.44%
ALDX Aldeyra Therapeutics, Inc. Buy 9.83% 0%
NVCR NovoCure Limited Buy 9.83% 0%
The percentage of cash held in the portfolio is: 51.17%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
MGNX MacroGenics, Inc. Buy 9.36% -5.41%
ESPR Esperion Therapeutics, Inc. Buy 9.84% -0.55%
TVTX Travere Therapeutics, Inc. Buy 10.31% 4.69%
ALDX Aldeyra Therapeutics, Inc. Buy 9.78% 0%
The percentage of cash held in the portfolio is: 60.7%
New Assets Added
  • ALDX
Assets Removed
Asset Action Perf %
PODD Sell All 3.96%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 10.17% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 9.02% -10.38%
MGNX MacroGenics, Inc. Buy 9.31% -6.55%
ESPR Esperion Therapeutics, Inc. Buy 9.97% 0%
TVTX Travere Therapeutics, Inc. Buy 9.92% 0%
The percentage of cash held in the portfolio is: 51.61%
New Assets Added
  • TVTX
Assets Removed
Asset Action Perf %
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-09-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
NEOG Neogen Corporation Buy 9.97% 0.35%
PODD Insulet Corporation Buy 9.78% -0.81%
EGRX Eagle Pharmaceuticals, Inc. Buy 9.75% -1.15%
MGNX MacroGenics, Inc. Buy 9.76% 0%
ESPR Esperion Therapeutics, Inc. Buy 9.76% 0%
The percentage of cash held in the portfolio is: 50.98%
New Assets Added
None
Assets Removed
Asset Action Perf %
CERS Sell All NA
AADI Sell All NA
Assets Rebalanced
None
2024-09-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
CERS Cerus Corporation Buy 9.42% -5.04%
AADI Aadi Bioscience, Inc. Buy 10.26% 3.43%
NEOG Neogen Corporation Buy 9.97% 0.35%
PODD Insulet Corporation Buy 9.78% -0.81%
EGRX Eagle Pharmaceuticals, Inc. Buy 9.75% -1.15%
MGNX MacroGenics, Inc. Buy 9.76% 0%
ESPR Esperion Therapeutics, Inc. Buy 9.76% 0%
The percentage of cash held in the portfolio is: 31.29%
New Assets Added
  • MGNX
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2024-08-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
CERS Cerus Corporation Buy 9.55% -3.78%
AADI Aadi Bioscience, Inc. Buy 9.92% 0%
NEOG Neogen Corporation Buy 9.89% -0.41%
PODD Insulet Corporation Buy 9.89% 0.36%
EGRX Eagle Pharmaceuticals, Inc. Buy 9.93% 0.77%
The percentage of cash held in the portfolio is: 50.82%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All 2.62%
AGEN Sell All -8.78%
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 10.37% 3.79%
AGEN Agenus Inc. Buy 9.33% -6.58%
CERS Cerus Corporation Buy 9.39% -5.88%
AADI Aadi Bioscience, Inc. Buy 9.58% -4%
NEOG Neogen Corporation Buy 9.77% -2.15%
PODD Insulet Corporation Buy 9.91% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 9.91% 0%
The percentage of cash held in the portfolio is: 31.74%
New Assets Added
  • PODD
  • EGRX
Assets Removed
Asset Action Perf %
ARDX Sell All -3.45%
APLS Sell All -4.2%
ORGO Sell All 3.53%
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.55% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 9.72% -0.64%
ORGO Organogenesis Holdings Inc. Buy 10.16% 3.89%
CARA Cara Therapeutics, Inc. Buy 10.24% 4.66%
AGEN Agenus Inc. Buy 10.07% 2.93%
CERS Cerus Corporation Buy 9.53% -2.52%
AADI Aadi Bioscience, Inc. Buy 9.38% -4%
NEOG Neogen Corporation Buy 9.78% 0%
The percentage of cash held in the portfolio is: 21.57%
New Assets Added
  • NEOG
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.51% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 9.6% -0.05%
ORGO Organogenesis Holdings Inc. Buy 10.28% 7.07%
CARA Cara Therapeutics, Inc. Buy 10.36% 7.87%
AGEN Agenus Inc. Buy 10.3% 7.31%
CERS Cerus Corporation Buy 9.59% 0%
AADI Aadi Bioscience, Inc. Buy 9.59% 0%
The percentage of cash held in the portfolio is: 30.77%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.4% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 9.72% -1.79%
ORGO Organogenesis Holdings Inc. Buy 9.61% -2.83%
CARA Cara Therapeutics, Inc. Buy 9.9% 0%
AGEN Agenus Inc. Buy 9.9% 0%
The percentage of cash held in the portfolio is: 51.48%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.8% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 9.8% 0%
ORGO Organogenesis Holdings Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 70.6%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-07 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
RMD Sell All 5.19%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
RMD ResMed Inc. Buy 9.52% 7.5%
The percentage of cash held in the portfolio is: 90.48%
New Assets Added
None
Assets Removed
Asset Action Perf %
CYH Sell All -1.96%
HQY Sell All -11.82%
SAVA Sell All 95.11%
SAGE Sell All -12.65%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 10.16% 1.38%
HQY HealthEquity, Inc. Buy 9.7% -3.16%
SAVA Cassava Sciences, Inc. Buy 11.8% 17.76%
SAGE Sage Therapeutics, Inc. Buy 9.85% -1.73%
HCSG Healthcare Services Group, Inc. Buy 9.73% -0.43%
RMD ResMed Inc. Buy 9.35% 0%
The percentage of cash held in the portfolio is: 39.4%
New Assets Added
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
FATE Sell All -7.9%
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
FATE Fate Therapeutics, Inc. Buy 9.53% -2.87%
CLDX Celldex Therapeutics, Inc. Buy 9.39% -4.26%
SMTI Sanara MedTech Inc. Buy 9.27% -5.45%
CYH Community Health Systems, Inc. Buy 9.98% 1.77%
HQY HealthEquity, Inc. Buy 9.64% -1.69%
SAVA Cassava Sciences, Inc. Buy 11.85% 20.78%
SAGE Sage Therapeutics, Inc. Buy 9.65% -1.64%
HCSG Healthcare Services Group, Inc. Buy 9.57% 0%
The percentage of cash held in the portfolio is: 21.13%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
PTGX Sell All -7.35%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
FATE Fate Therapeutics, Inc. Buy 9.61% -2.33%
PTGX Protagonist Therapeutics, Inc. Buy 9.47% -3.84%
CLDX Celldex Therapeutics, Inc. Buy 10% 1.6%
SMTI Sanara MedTech Inc. Buy 9.85% 0%
CYH Community Health Systems, Inc. Buy 9.85% 0%
HQY HealthEquity, Inc. Buy 9.85% 0%
SAVA Cassava Sciences, Inc. Buy 9.85% 0%
SAGE Sage Therapeutics, Inc. Buy 9.85% 0%
The percentage of cash held in the portfolio is: 21.69%
New Assets Added
  • SMTI
  • CYH
  • HQY
  • SAVA
  • SAGE
Assets Removed
None
Assets Rebalanced
None
2024-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
FATE Fate Therapeutics, Inc. Buy 9.54% -3.05%
PTGX Protagonist Therapeutics, Inc. Buy 9.76% -0.76%
CLDX Celldex Therapeutics, Inc. Buy 9.84% 0%
The percentage of cash held in the portfolio is: 70.86%
New Assets Added
  • CLDX
Assets Removed
None
Assets Rebalanced
None
2024-07-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
FATE Fate Therapeutics, Inc. Buy 9.18% -7%
PTGX Protagonist Therapeutics, Inc. Buy 9.87% 0%
The percentage of cash held in the portfolio is: 80.95%
New Assets Added
  • PTGX
Assets Removed
None
Assets Rebalanced
None
2024-07-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
FATE Fate Therapeutics, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 90.2%
New Assets Added
  • FATE
Assets Removed
None
Assets Rebalanced
None
2024-07-22 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
VCYT Sell All -8.31%
Assets Rebalanced
None
2024-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCYT Veracyte, Inc. Buy 9.34% -5.34%
The percentage of cash held in the portfolio is: 90.66%
New Assets Added
None
Assets Removed
Asset Action Perf %
WST Sell All -5.09%
ANGO Sell All 13.38%
CYH Sell All 1.62%
TDOC Sell All -0.64%
SGRY Sell All 13.89%
AVNS Sell All 5.95%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
WST West Pharmaceutical Services, Inc. Buy 8.94% -1.88%
ANGO AngioDynamics, Inc. Buy 11% 20.72%
CYH Community Health Systems, Inc. Buy 9.67% 6.2%
TDOC Teladoc Health, Inc. Buy 9.75% 7.04%
SGRY Surgery Partners, Inc. Buy 10.54% 15.66%
AVNS Avanos Medical, Inc. Buy 9.74% 6.89%
VCYT Veracyte, Inc. Buy 9.59% 0%
The percentage of cash held in the portfolio is: 30.77%
New Assets Added
  • VCYT
Assets Removed
Asset Action Perf %
BHVN Sell All 0.3%
PDSB Sell All 13.92%
ALT Sell All 0.13%
OPK Sell All 7.58%
Assets Rebalanced
None
2024-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.58% 10.23%
BHVN Biohaven Ltd. Buy 10.07% 4.89%
ALT Altimmune, Inc. Buy 9.85% 2.67%
OPK OPKO Health, Inc. Buy 9.96% 3.79%
WST West Pharmaceutical Services, Inc. Buy 9.59% 0%
ANGO AngioDynamics, Inc. Buy 9.59% 0%
CYH Community Health Systems, Inc. Buy 9.59% 0%
TDOC Teladoc Health, Inc. Buy 9.59% 0%
SGRY Surgery Partners, Inc. Buy 9.59% 0%
AVNS Avanos Medical, Inc. Buy 9.59% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • WST
  • ANGO
  • CYH
  • TDOC
  • SGRY
  • AVNS
Assets Removed
None
Assets Rebalanced
None
2024-07-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 9.8% 0%
BHVN Biohaven Ltd. Buy 9.8% 0%
ALT Altimmune, Inc. Buy 9.8% 0%
OPK OPKO Health, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 60.8%
New Assets Added
  • PDSB
  • BHVN
  • ALT
  • OPK
Assets Removed
None
Assets Rebalanced
None
2024-07-09 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
VERU Sell All -3.41%
NVRO Sell All -2.79%
VRDN Sell All -6.81%
RYTM Sell All 2.55%
Assets Rebalanced
None
2024-07-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVRO Nevro Corp. Buy 10.18% -2.67%
VRDN Viridian Therapeutics, Inc. Buy 9.7% -7.27%
RYTM Rhythm Pharmaceuticals, Inc. Buy 10% -4.36%
VERU Veru Inc. Buy 10.82% 3.41%
The percentage of cash held in the portfolio is: 59.3%
New Assets Added
None
Assets Removed
Asset Action Perf %
CYH Sell All NA
Assets Rebalanced
None
2024-07-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 10.55% 7.19%
NVRO Nevro Corp. Buy 10.05% -3.02%
VRDN Viridian Therapeutics, Inc. Buy 9.54% -7.95%
RYTM Rhythm Pharmaceuticals, Inc. Buy 10.28% -0.77%
VERU Veru Inc. Buy 11.19% 7.95%
The percentage of cash held in the portfolio is: 48.38%
New Assets Added
None
Assets Removed
Asset Action Perf %
CHRS Sell All -19.65%
STAA Sell All 5.2%
RARE Sell All 2.79%
ARDX Sell All -28.74%
Assets Rebalanced
None
2024-07-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
STAA STAAR Surgical Company Buy 10.77% 12.05%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.92% 3.19%
CYH Community Health Systems, Inc. Buy 9.72% 3.75%
ARDX Ardelyx, Inc. Buy 9.56% 2.16%
CHRS Coherus BioSciences, Inc. Buy 8.71% -6.94%
NVRO Nevro Corp. Buy 9.86% 0%
VRDN Viridian Therapeutics, Inc. Buy 9.86% 0%
RYTM Rhythm Pharmaceuticals, Inc. Buy 9.86% 0%
VERU Veru Inc. Buy 9.86% 0%
The percentage of cash held in the portfolio is: 11.86%
New Assets Added
  • NVRO
  • VRDN
  • RYTM
  • VERU
Assets Removed
Asset Action Perf %
ACAD Sell All 1.01%
MNKD Sell All -6.26%
EGRX Sell All 23.44%
Assets Rebalanced
None
2024-07-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.72% 2.33%
MNKD MannKind Corporation Buy 9.14% -3.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.88% 25%
STAA STAAR Surgical Company Buy 10.69% 12.5%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.8% 3.14%
CYH Community Health Systems, Inc. Buy 9.73% 5%
ARDX Ardelyx, Inc. Buy 9.26% 0%
CHRS Coherus BioSciences, Inc. Buy 9.26% 0%
The percentage of cash held in the portfolio is: 20.52%
New Assets Added
  • ARDX
  • CHRS
Assets Removed
None
Assets Rebalanced
None
2024-06-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.96% 3.09%
MNKD MannKind Corporation Buy 9.41% -2.58%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.82% 12.05%
STAA STAAR Surgical Company Buy 10.68% 10.52%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.04% 3.94%
CYH Community Health Systems, Inc. Buy 9.42% 0%
The percentage of cash held in the portfolio is: 39.67%
New Assets Added
  • CYH
Assets Removed
None
Assets Rebalanced
None
2024-06-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.56% -2.39%
MNKD MannKind Corporation Buy 9.37% -4.42%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.76% 9.82%
STAA STAAR Surgical Company Buy 10.54% 7.54%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.97% 1.71%
The percentage of cash held in the portfolio is: 49.8%
New Assets Added
None
Assets Removed
Asset Action Perf %
FGEN Sell All -12.08%
Assets Rebalanced
None
2024-06-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.69% -1.76%
MNKD MannKind Corporation Buy 9.51% -3.5%
FGEN FibroGen, Inc. Buy 9.61% -2.5%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.01% 1.56%
STAA STAAR Surgical Company Buy 9.86% 0%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.86% 0%
The percentage of cash held in the portfolio is: 41.45%
New Assets Added
  • STAA
  • RARE
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.8% 0%
MNKD MannKind Corporation Buy 9.8% 0%
FGEN FibroGen, Inc. Buy 9.8% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 60.8%
New Assets Added
  • ACAD
  • MNKD
  • FGEN
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-05-23 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Sell All -2.32%
Assets Rebalanced
None
2024-05-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 8.95% -1.4%
The percentage of cash held in the portfolio is: 91.05%
New Assets Added
None
Assets Removed
Asset Action Perf %
BLFS Sell All -3.34%
CYH Sell All -2.94%
OMI Sell All -10.67%
CUTR Sell All -7.69%
Assets Rebalanced
None
2024-05-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLFS BioLife Solutions, Inc. Buy 9.61% -2.67%
CYH Community Health Systems, Inc. Buy 9.61% -2.67%
OMI Owens & Minor, Inc. Buy 8.98% -9%
CUTR Cutera, Inc. Buy 9.03% -8.5%
PODD Insulet Corporation Buy 8.99% -0.67%
The percentage of cash held in the portfolio is: 53.78%
New Assets Added
None
Assets Removed
Asset Action Perf %
VCYT Sell All -0.89%
AVXL Sell All 11.03%
EDIT Sell All -3.33%
PACB Sell All -0.52%
Assets Rebalanced
None
2024-05-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCYT Veracyte, Inc. Buy 9.92% 1.69%
AVXL Anavex Life Sciences Corp. Buy 11.12% 14.04%
EDIT Editas Medicine, Inc. Buy 9.6% -1.58%
PACB Pacific Biosciences of California, Inc. Buy 10.21% 4.66%
BLFS BioLife Solutions, Inc. Buy 9.52% -2.1%
CYH Community Health Systems, Inc. Buy 9.39% -3.48%
OMI Owens & Minor, Inc. Buy 9.15% -5.86%
CUTR Cutera, Inc. Buy 8.74% -10.12%
PODD Insulet Corporation Buy 9.01% 1.02%
The percentage of cash held in the portfolio is: 13.34%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGMO Sell All 16.07%
Assets Rebalanced
None
2024-05-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGMO Sangamo Therapeutics, Inc. Buy 10.44% 8.93%
VCYT Veracyte, Inc. Buy 9.98% 4%
AVXL Anavex Life Sciences Corp. Buy 10.82% 12.78%
EDIT Editas Medicine, Inc. Buy 9.9% 3.15%
PACB Pacific Biosciences of California, Inc. Buy 10.89% 13.47%
BLFS BioLife Solutions, Inc. Buy 9.37% -2.05%
CYH Community Health Systems, Inc. Buy 9.49% -0.8%
OMI Owens & Minor, Inc. Buy 9.24% -3.39%
CUTR Cutera, Inc. Buy 9.1% -4.86%
PODD Insulet Corporation Buy 8.77% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • PODD
Assets Removed
Asset Action Perf %
MD Sell All -8.68%
Assets Rebalanced
None
2024-05-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGMO Sangamo Therapeutics, Inc. Buy 9.72% 1.79%
MD Pediatrix Medical Group, Inc. Buy 9.5% -0.59%
VCYT Veracyte, Inc. Buy 9.78% 2.31%
AVXL Anavex Life Sciences Corp. Buy 10.33% 8.02%
EDIT Editas Medicine, Inc. Buy 9.51% -0.53%
PACB Pacific Biosciences of California, Inc. Buy 11.04% 15.54%
BLFS BioLife Solutions, Inc. Buy 9.53% 0%
CYH Community Health Systems, Inc. Buy 9.53% 0%
OMI Owens & Minor, Inc. Buy 9.53% 0%
CUTR Cutera, Inc. Buy 9.53% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • BLFS
  • CYH
  • OMI
  • CUTR
Assets Removed
Asset Action Perf %
MOH Sell All 0.04%
Assets Rebalanced
None
2024-05-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
MOH Molina Healthcare, Inc. Buy 9.82% 0.72%
SGMO Sangamo Therapeutics, Inc. Buy 9.63% -1.79%
MD Pediatrix Medical Group, Inc. Buy 9.82% 0%
VCYT Veracyte, Inc. Buy 9.82% 0%
AVXL Anavex Life Sciences Corp. Buy 9.82% 0%
EDIT Editas Medicine, Inc. Buy 9.82% 0%
PACB Pacific Biosciences of California, Inc. Buy 9.82% 0%
The percentage of cash held in the portfolio is: 31.45%
New Assets Added
  • MD
  • VCYT
  • AVXL
  • EDIT
  • PACB
Assets Removed
Asset Action Perf %
ABUS Sell All 3.21%
Assets Rebalanced
None
2024-05-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
ABUS Arbutus Biopharma Corporation Buy 9.82% 2.86%
MOH Molina Healthcare, Inc. Buy 9.86% 1.37%
SGMO Sangamo Therapeutics, Inc. Buy 9.79% 0%
The percentage of cash held in the portfolio is: 70.52%
New Assets Added
  • SGMO
Assets Removed
Asset Action Perf %
OMCL Sell All -0.03%
NUTX Sell All -7.18%
Assets Rebalanced
None
2024-05-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMCL Omnicell, Inc. Buy 10.77% -0.56%
NUTX Nutex Health Inc. Buy 10.31% -4.82%
ABUS Arbutus Biopharma Corporation Buy 9.71% 1.43%
MOH Molina Healthcare, Inc. Buy 9.6% -1.55%
The percentage of cash held in the portfolio is: 59.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
BLUE Sell All -3%
PEN Sell All -4.03%
INGN Sell All 16.88%
ACRS Sell All -3.17%
IOVA Sell All 7.12%
SGMO Sell All -7.41%
Assets Rebalanced
None
2024-05-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
INGN Inogen, Inc. Buy 9.69% 3.55%
ACRS Aclaris Therapeutics, Inc. Buy 9.95% 6.35%
IOVA Iovance Biotherapeutics, Inc. Buy 10.46% 11.84%
SGMO Sangamo Therapeutics, Inc. Buy 9.35% 0%
OMCL Omnicell, Inc. Buy 10.77% 0.56%
NUTX Nutex Health Inc. Buy 9.59% -10.41%
PEN Penumbra, Inc. Buy 9.39% -0.77%
ABUS Arbutus Biopharma Corporation Buy 9.6% 1.43%
BLUE bluebird bio, Inc. Buy 9.56% 1%
MOH Molina Healthcare, Inc. Buy 9.64% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MOH
Assets Removed
Asset Action Perf %
SENS Sell All 2.87%
Assets Rebalanced
None
2024-05-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
SENS Senseonics Holdings, Inc. Buy 9.68% 3.49%
INGN Inogen, Inc. Buy 9.52% 1.99%
ACRS Aclaris Therapeutics, Inc. Buy 9.71% 3.97%
IOVA Iovance Biotherapeutics, Inc. Buy 10.37% 11.04%
SGMO Sangamo Therapeutics, Inc. Buy 9.17% -1.85%
OMCL Omnicell, Inc. Buy 10.63% -0.5%
NUTX Nutex Health Inc. Buy 10.58% -1%
PEN Penumbra, Inc. Buy 9.45% 0%
ABUS Arbutus Biopharma Corporation Buy 9.45% 0%
BLUE bluebird bio, Inc. Buy 9.45% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • PEN
  • ABUS
  • BLUE
Assets Removed
Asset Action Perf %
IBRX Sell All -13.13%
CDMO Sell All 11.38%
CARA Sell All 4.5%
Assets Rebalanced
None
2024-05-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
IBRX ImmunityBio, Inc. Buy 9.35% 1.78%
CDMO Avid Bioservices, Inc. Buy 10.02% 9.13%
CARA Cara Therapeutics, Inc. Buy 9.45% 2.94%
SENS Senseonics Holdings, Inc. Buy 9.53% 3.68%
INGN Inogen, Inc. Buy 9.3% 1.42%
ACRS Aclaris Therapeutics, Inc. Buy 9.9% 7.94%
IOVA Iovance Biotherapeutics, Inc. Buy 10% 9.04%
SGMO Sangamo Therapeutics, Inc. Buy 9.44% 2.93%
OMCL Omnicell, Inc. Buy 10.5% 0%
NUTX Nutex Health Inc. Buy 10.5% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • OMCL
  • NUTX
Assets Removed
Asset Action Perf %
SMMT Sell All 13.73%
PTCT Sell All 15.54%
Assets Rebalanced
None
2024-05-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 11.35% 19.57%
SMMT Summit Therapeutics Inc. Buy 11.56% 21.76%
IBRX ImmunityBio, Inc. Buy 9.01% -5.01%
CDMO Avid Bioservices, Inc. Buy 9.63% 1.46%
CARA Cara Therapeutics, Inc. Buy 9.53% 0.4%
SENS Senseonics Holdings, Inc. Buy 9.02% -4.93%
INGN Inogen, Inc. Buy 9.48% 0%
ACRS Aclaris Therapeutics, Inc. Buy 9.48% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 9.48% 0%
SGMO Sangamo Therapeutics, Inc. Buy 9.48% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • INGN
  • ACRS
  • IOVA
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-05-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 10.99% 12.53%
SMMT Summit Therapeutics Inc. Buy 9.94% 1.81%
IBRX ImmunityBio, Inc. Buy 8.68% -11.12%
CDMO Avid Bioservices, Inc. Buy 9.85% 0.93%
CARA Cara Therapeutics, Inc. Buy 9.71% -0.53%
SENS Senseonics Holdings, Inc. Buy 9.77% 0%
The percentage of cash held in the portfolio is: 41.06%
New Assets Added
  • SENS
Assets Removed
None
Assets Rebalanced
None
2024-04-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 10.89% 12.5%
SMMT Summit Therapeutics Inc. Buy 9.73% 0.52%
IBRX ImmunityBio, Inc. Buy 9.67% 0%
CDMO Avid Bioservices, Inc. Buy 9.67% 0%
CARA Cara Therapeutics, Inc. Buy 9.67% 0%
The percentage of cash held in the portfolio is: 50.37%
New Assets Added
  • IBRX
  • CDMO
  • CARA
Assets Removed
None
Assets Rebalanced
None
2024-04-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 9.8% 0%
SMMT Summit Therapeutics Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • PTCT
  • SMMT
Assets Removed
None
Assets Rebalanced
None
2024-04-09 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All 6.87%
Assets Rebalanced
None
2024-04-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 10.12% 3.82%
The percentage of cash held in the portfolio is: 89.88%
New Assets Added
None
Assets Removed
Asset Action Perf %
RVNC Sell All -10.37%
LXRX Sell All -14.17%
Assets Rebalanced
None
2024-04-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
RVNC Revance Therapeutics, Inc. Buy 9.46% -7.52%
LXRX Lexicon Pharmaceuticals, Inc. Buy 8.69% -15%
OPK OPKO Health, Inc. Buy 10.04% 3.05%
The percentage of cash held in the portfolio is: 71.82%
New Assets Added
None
Assets Removed
Asset Action Perf %
ANGO Sell All 6.67%
TNDM Sell All -2.95%
KIDS Sell All -5.45%
ACRS Sell All -0.79%
Assets Rebalanced
None
2024-04-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 11.09% 8.6%
TNDM Tandem Diabetes Care, Inc. Buy 9.69% -5.1%
KIDS OrthoPediatrics Corp. Buy 9.41% -7.9%
ACRS Aclaris Therapeutics, Inc. Buy 9.89% -3.17%
RVNC Revance Therapeutics, Inc. Buy 9.36% -8.33%
LXRX Lexicon Pharmaceuticals, Inc. Buy 9.4% -7.92%
OPK OPKO Health, Inc. Buy 10.02% 3.05%
The percentage of cash held in the portfolio is: 31.12%
New Assets Added
None
Assets Removed
Asset Action Perf %
VCYT Sell All -5.57%
Assets Rebalanced
None
2024-04-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 10.31% 2.28%
TNDM Tandem Diabetes Care, Inc. Buy 9.67% -4.11%
KIDS OrthoPediatrics Corp. Buy 9.81% -2.69%
ACRS Aclaris Therapeutics, Inc. Buy 10.08% 0%
VCYT Veracyte, Inc. Buy 10.05% -0.37%
RVNC Revance Therapeutics, Inc. Buy 9.69% -3.86%
LXRX Lexicon Pharmaceuticals, Inc. Buy 9.58% -5%
OPK OPKO Health, Inc. Buy 9.6% 0%
The percentage of cash held in the portfolio is: 21.2%
New Assets Added
  • OPK
Assets Removed
Asset Action Perf %
OFIX Sell All -3.17%
ATRI Sell All -11.81%
Assets Rebalanced
None
2024-03-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 10.05% 2.98%
TNDM Tandem Diabetes Care, Inc. Buy 9.79% 0.31%
KIDS OrthoPediatrics Corp. Buy 9.82% 0.66%
ACRS Aclaris Therapeutics, Inc. Buy 9.6% -1.59%
VCYT Veracyte, Inc. Buy 9.96% 2.03%
ATRI Atrion Corporation Buy 9.76% 0%
OFIX Orthofix Medical Inc. Buy 9.76% 0%
RVNC Revance Therapeutics, Inc. Buy 9.76% 0%
LXRX Lexicon Pharmaceuticals, Inc. Buy 9.76% 0%
The percentage of cash held in the portfolio is: 11.76%
New Assets Added
  • ATRI
  • OFIX
  • RVNC
  • LXRX
Assets Removed
None
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings